Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | The MGP panel: a targeted genomics panel to identify cytogenetic abnormalities in multiple myeloma

Rafat Abonour • 26 Aug 2022
IMS 2022
Multiple Myeloma

Rafat Abonour, MD, Indiana University School of Medicine, Indianapolis, IN, comments on the potential of the MGP panel, a targeted sequencing panel to identify common cytogenetic abnormalities in multiple myeloma, suggesting this new panel may replace the use of fluorescence in situ hybridization (FISH). This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Rafat Abonour

1:26
Determining the prevalence of MGUS & deciphering the mechanisms of disease progression
Rafat Abonour • 26 Aug 2022
1:05
Insights into Connect® MM & the need for better designed clinical trials
Rafat Abonour • 26 Aug 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals